David Silberman - Chief Financial Officer at Oramed Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ORMP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Silberman since 12/23/2023

Holdings reported by David Silberman for Oramed Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 367K $810K $2.21 Jan 4, 2024 Direct

Transactions reported by David Silberman for Oramed Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.